Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trebor Rx was a Canadian healthcare products and personal protective equipment manufacturer focused on masks, respirators, face shields, and related protective products for healthcare, frontline, and essential workers. The company emerged during the COVID-19 period and marketed made-in-Canada PPE, including surgical and respirator masks, and worked with ZEN Graphene Solutions on antimicrobial mask technology marketed as CAREGuard+ with ZENGuard technology. Trebor Rx operated production facilities in Collingwood, Ontario, and Edmonton, Alberta. However, the company was placed into court-appointed receivership in July 2022, and receiver-related court records remained active through its discharge process in 2023. As a result, Trebor Rx appears to be an inactive/closed operating business rather than an ongoing independent biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trebor Rx.